[18F]F-AraG PET Imaging in Alzheimer's Disease

This study evaluates the use of \[18F\]F-AraG PET/CT imaging to quantify activated T cell involvement in patients with Alzheimer's disease (AD). Participants will undergo total-body dynamic PET imaging to assess tracer uptake in the brain and peripheral organs. Results will be compared between participants with AD and healthy controls to characterize both central nervous system and systemic immune alterations in AD

NCT Number	NCT07611357
Lead Sponsor	CellSight Technologies, Inc. Collaborators: University of California, Davis
Conditions	Alzheimer Disease (AD)
Enrollment	10 participants
Start Date	2026-05-16
Primary Completion	2029-09-16 (estimated)
Study Completion	2029-12-16 (estimated)
Updated on ClinicalTrials.gov	2026-05-28